Meihua International Medical Technologies Co., Ltd.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $61.8M | $96.9M | $97.1M | $103.3M | $104.0M | $89.1M | $79.6M |
| Cost of Revenue | $42.6M | $63.6M | $63.9M | $65.2M | $64.2M | $51.9M | $47.4M |
| Gross Profit | $19.2M | $33.3M | $33.2M | $38.1M | $39.8M | $37.2M | $32.2M |
| Gross Margin | 31.0% | 34.4% | 34.2% | 36.9% | 38.3% | 41.7% | 40.5% |
| Operating Expenses | |||||||
| Research & Development | $2.4M | $3.5M | $2.8M | $3.0M | $2.7M | $2.5M | $3.2M |
| SG&A Expense | $3.2M | $7.8M | $6.5M | $12.5M | $4.4M | $4.6M | $4.2M |
| Operating Income | $8.3M | $14.3M | $14.7M | $10.8M | $26.3M | $23.5M | $19.4M |
| Operating Margin | 13.4% | 14.8% | 15.1% | 10.5% | 25.2% | 26.3% | 24.3% |
| Interest Expense | $241.5K | $247.6K | $250.8K | $191.2K | $180.7K | $137.2K | $97.8K |
| Pretax Income | $9.4M | $13.6M | $15.0M | $10.9M | $26.2M | $23.7M | $19.2M |
| Income Tax Expense | $2.6M | $2.8M | $3.5M | $4.7M | $5.3M | $4.7M | $3.8M |
| Net Income | $6.8M | $10.8M | $11.6M | $6.2M | $20.9M | $19.0M | $15.4M |
| Net Margin | 11.0% | 11.2% | 12.0% | 6.0% | 20.1% | 21.4% | 19.4% |
| EPS (Basic) | $18.04 | $39.62 | $48.56 | $0.27 | $0.01 | $0.01 | $0.01 |
| EPS (Diluted) | $18.04 | $39.62 | $48.56 | $0.00 | $0.01 | $0.01 | — |
| Shares Outstanding (Basic) | 376.0K | 27.4M | 239.4K | 23.4M | 2.28B | 2.28B | 2.12B |
| Shares Outstanding (Diluted) | 376.0K | 27.4M | 239.4K | 23.4M | 2.28B | 2.28B | 2.12B |
| Dividends Per Share | — | — | — | — | — | — | — |